Blacksmith Medicines: Funding, Investors & Team (Oct 2026)
Blacksmith Medicines developing medicines targeting metal-dependent enzymes found in human physiology. Over 30% of known enzymes are metalloenzymes, covering all major enzyme classes: oxidoreductases, transferases, hydrolases, lyases, isomerases, and ligases. Metal ions, including magnesium, zinc, iron, manganese and copper, are the essential ingredient in these metalloenzymes.
Blacksmith Medicines has raised $3.3M across 1 funding round on record, the most recent an undisclosed round of $3.3M announced in Feb 2024.
That round is below the $8.4M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Blacksmith Medicines Company Profile and Key Stats
Latest funding round on record: Feb 2024.
Blacksmith Medicines Funding Rounds
Blacksmith Medicines Founders and Leadership Team
No contact details are on record for this team yet.
Blacksmith Medicines Funding Compared to Other Biotechnology Startups
Blacksmith Medicines' latest round of $3.3M is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Blacksmith Medicines in Biotechnology and San Diego
Companies Similar to Blacksmith Medicines
Prolific Machines is a biotech company located in San Francisco, California, that was established in 2020. It…
Altay Therapeutics is a biotech company focused on finding and discovering small molecule therapies for…
Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…
Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…
Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…
Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…
Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.
Serán is a contract development and manufacturing organization providing a comprehensive suite of…
Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…
Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…
Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…
Blacksmith Medicines Funding FAQs
What does Blacksmith Medicines do?
Blacksmith Medicines developing medicines targeting metal-dependent enzymes found in human physiology. Over 30% of known enzymes are metalloenzymes, covering all major enzyme classes: oxidoreductases, transferases, hydrolases, lyases, isomerases, and ligases. Metal ions, including magnesium, zinc, iron, manganese and copper, are the essential ingredient in these metalloenzymes.
How much funding has Blacksmith Medicines raised?
Blacksmith Medicines has raised $3.3M across 1 round on record. The most recent is an undisclosed round of $3.3M announced in Feb 2024.
When did Blacksmith Medicines last raise funding?
Blacksmith Medicines' most recent funding round on record is an undisclosed round of $3.3M, announced in Feb 2024.
Who founded Blacksmith Medicines?
FundedIQ lists Zachary Zimmerman (Founder) at Blacksmith Medicines.
Where is Blacksmith Medicines headquartered?
Blacksmith Medicines is based in San Diego, California, United States.
How many employees does Blacksmith Medicines have?
Blacksmith Medicines is in the 11-50 employee band.
How does Blacksmith Medicines' funding compare to other Biotechnology startups?
Blacksmith Medicines' latest round of $3.3M is below the $8.4M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's Blacksmith Medicines Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Blacksmith Medicines is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.